BRC Operations Pty. Ltd.   Report issue

For profit Phase 4
Founded: Ultimo Australia (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2008
NCT00693849
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Disease (Phase 4)

Hyperkinesis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4